Disease associated variation - GWASdb |
Chr | Pos | SNP ID(dbSNP 142) | Ref | Alt | Ori SNP ID | P-value | Drug Name | Drug Anno | GWAS Trait | HPO ID | DO ID | AA | Type | Trait or Drug |
15 | 84205679 | rs17841192 | C | T | rs17841192 | 4.22E-04 | ALDOSTERONE | BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | HPOID:0011025 | DOID:10763 | C | intron | GWASdb_drug |
15 | 84235930 | rs2562769 | G | T | rs2562769 | 2.95E-04 | ATORVASTATIN | SERINE ENDOPEPTIDASES|PYRROLES|PCSK9 PROTEIN, HUMAN|HEPTANOIC ACIDS|APOLIPOPROTEINS E|PROPROTEIN CONVERTASES | Response to statin treatment (atorvastatin), change in cholesterol levels | HPOID:0001626 | DOID:1287 | A | intron | GWASdb_drug |
15 | 84257351 | rs7182482 | G | A | rs7182482 | 3.06E-04 | ATORVASTATIN | SERINE ENDOPEPTIDASES|PYRROLES|PCSK9 PROTEIN, HUMAN|HEPTANOIC ACIDS|APOLIPOPROTEINS E|PROPROTEIN CONVERTASES | Response to statin treatment (atorvastatin), change in cholesterol levels | HPOID:0001626 | DOID:1287 | G | intron | GWASdb_drug |
15 | 84129515 | rs6602977 | A | G | rs6602977 | 9.47E-05 | | | Orofacial clefts | HPOID:0000202 | DOID:0050567 | G | intron | GWASdb_trait |
15 | 84135138 | rs9920377 | G | A | rs9920377 | 6.37E-04 | | | Response to taxane treatment (placlitaxel) | HPOID:0100526 | DOID:1324 | A | intron | GWASdb_trait |
15 | 84173859 | rs10906975 | A | G | rs10906975 | 3.59E-04 | | | Body mass index | HPOID:0001507 | DOID:9970 | G | intron | GWASdb_trait |
15 | 84173859 | rs10906975 | A | G | rs10906975 | 4.96E-04 | | | Body mass index | HPOID:0001507 | DOID:9970 | G | intron | GWASdb_trait |
15 | 84178679 | rs1491579 | T | C | rs1491579 | 1.47E-05 | | | Alcohol consumption | HPOID:0000707 | DOID:1574|DOID:0050741 | T | intron | GWASdb_trait |
15 | 84179115 | rs12905964 | C | T | rs12905964 | 8.63E-05 | | | Alcohol consumption | HPOID:0000707 | DOID:1574|DOID:0050741 | C | intron | GWASdb_trait |
15 | 84201446 | rs2732150 | T | C | rs2732150 | 4.86E-04 | | | Coronary Artery Disease | HPOID:0001677 | DOID:3393 | T | intron | GWASdb_trait |
15 | 84203402 | rs2642820 | A | G | rs2642820 | 6.10E-06 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | A | intron | GWASdb_trait |
15 | 84205565 | rs2201101 | G | T | rs2201101 | 8.73E-05 | | | Blood Pressure | HPOID:0011025 | DOID:10763 | T | intron | GWASdb_trait |
15 | 84205679 | rs17841192 | C | T | rs17841192 | 4.22E-04 | | | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | HPOID:0011025 | DOID:10763 | C | intron | GWASdb_trait |
15 | 84235930 | rs2562769 | G | T | rs2562769 | 2.95E-04 | | | Response to statin treatment (atorvastatin), change in cholesterol levels | HPOID:0001626 | DOID:1287 | A | intron | GWASdb_trait |
15 | 84235930 | rs2562769 | G | T | rs2562769 | 1.10E-05 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | A | intron | GWASdb_trait |
15 | 84242585 | rs12900490 | T | C | rs12900490 | 2.90E-05 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | T | intron | GWASdb_trait |
15 | 84257351 | rs7182482 | G | A | rs7182482 | 3.06E-04 | | | Response to statin treatment (atorvastatin), change in cholesterol levels | HPOID:0001626 | DOID:1287 | G | intron | GWASdb_trait |
15 | 84263750 | rs2562764 | C | T | rs2562764 | 4.57E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | A | intron | GWASdb_trait |
15 | 84273405 | rs17158772 | A | G | rs17158772 | 4.40E-07 | | | Urinary metabolites | HPOID:0000079 | DOID:557 | A | intron | GWASdb_trait |
15 | 84274980 | rs1896796 | A | G | rs1896796 | 0.000171 | | | Schizophrenia | HPOID:0100753 | DOID:5419 | T | intron | GWASdb_trait |
15 | 84286492 | rs2562784 | A | G | rs2562784 | 6.00E-08 | | | Height | HPOID:0000002 | NA | T | intron | GWASdb_trait |